London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
You will only have one login account. Registering with multiple accounts is not allowed. Any user found to have more than one account on this site will have all, and any future accounts suspended permanently.
Your email and password must only be used by you. If a post is made under your account, it will be considered that it was posted by yourself.
Your account nickname must not be the same, or contain, listed company names or board members' names.
While debating and discussion is fine, we will not tolerate; rudeness, swearing, insulting posts, personal attacks, or posts which are invasive of another's privacy.
You will not;
discuss illegal or criminal activities.
post any confidential or price sensitive information or that is not public knowledge.
post misleading or false statements regarding the share price and performance. Such posts are deemed as market abuse, and may be reported to the appropriate authorities.
post any private communication, or part thereof, from any other person, including from a member of the board of directors of a listed company. Such posts cannot be verified as true and could be deemed to be misleading.
post any personal details (e.g. email address or phone number).
post live price or level 2 updates.
publish content that is not your original work, or infringes the copyright or other rights of any third party.
post non-constructive, meaningless, one word (or short) non-sense posts.
post links to, or otherwise publish any content containing any form of advertising, promotion for goods and services, spam, or other unsolicited communication.
post any affiliate or referral links, or post anything asking for a referral.
post or otherwise publish any content unrelated to the board or the board's topic.
re-post premium share chat posts on regular share chat.
restrict or inhibit any other user from using the boards.
impersonate any person or entity, including any of our employees or representatives.
post or transmit any content that contains software viruses, files or code designed to interrupt, destroy or limit the functionality of this website or any computer software or equipment.
If you are going to post non-English, please also post an English translation of your post.
If you are going to post non-English, please also post an English translation of your post.
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium and Verified Members
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Given that DSMV have been a major shareholder from the off, it is obvious that they saw the potential of Fruitflow early on. Yet another reason for fair to mean fair. Any way you try to slant it, a professional adviser would be liable if one party to a formal agreement was short changed. Maybe their motto is "We can't go on forever, with suspicious minds"
One post before I filter you, your agenda has always been to try and trick me in to getting banned.
Current revenues, increasing by achievable percentages period on period, will cross the baseline. Simple enough for all to appreciate.
The operating loss is consistently above the entire turnover of this company. A modest percentage increase in revenues would change nothing. It needs to be a gargantuan percentage increase in turnover to get anywhere near break even. Where will this gargantuan increase in turnover come from, China?
Musing on this question, that's all any of us can do because the terms are confidential.
The worst scenario would change matters. In the hypothetical case that all was lost, the shareholders and creditors would then have a right to investigate the cause of the demise. If investigation disclosed that DSM had bullied Provexis out of true value, or if it was shown that the independent advice (my understanding is that a stockbroker company gave this) was misleading to the market, the quite obviously recourse could then be sought.
A hypothesis, nothing more. I sincerely hope that there will be no need to see that scenario played out in reality.
Provexis need a modest percentage increase in revenues to change the outlook here. I think it is happening.
pumpky, Alf's right about the Independent Body. They did scrutinise the 2010 AA and deemed it to be fair although we were never told who they were and what brief they had.
Hopefully, they were fully independent of the remuneration committee!!
On the contrary Pumpky, what I posted is published fact, you are making defamatory claims against several people. You have a deeply cynical mindset, sometimes it has its comical moments, are you still accusing Provexis of funding the hairdresser on the ground floor of their offices in Windsor? Doesn't the farcical nature of that claim, which you pursued with equal certainty to the present libellous accusations, make you pause before you put on record such actionable defamation?
My sneers,please Pxs let us shareholders know how much you have sold ,and what the cut was? DSM are the major company, sp imho Pxs took what was on the table,to keep IF/DB in work ,sometimes Alf you do post sxxte xxx
You are talking about a legal document which has been judged fair by an independent body, and that body would be liable to prosecution if they lied.
Your sneers get close to defamation sometimes, be careful.
I cannot imagine a circumstance where China come for DSM or that DSM would entertain such an idea. PXS may be different if DSM feel they have put enough into it and cannot take it any further with their business model.
I would not want that as it is likely to be a cheap sell off with no benefit to investors.
The one thing I fear as to where we are is a sell off, it can only end in tears for peeps like us. Maybe if you have the confidence and the money with the element of further risk, it is a time to buy before Sept.
I sold a tranch a few months ago and then bought back at a lower price, so acquired more shares for my money.
Just some of my own thoughts, no recomendation.
Very fair comment Wheelds.
China market is changing so fast. the consumerist population already exceeds Europe. Their large companies have immense commercial strength.
Will they come for Provexis, or DSM ?
There's no trading indication at the moment IMHO
By-Health and Tomson Health have merged and have just recently bought out another Health company after buying out Life space group, and if you read the article they kept the negotiations all quiet until the final agreement;-
This article clearly shows By-Health is checking out Health care companies around the globe to meet the growing demand of the Chinese consumer and as below states they are ready and willing to buy other health companies out.
The article states:-
"This deal marks the latest case of many acquisitions made by China of an Australian healthcare companies as Chinese consumer demand in the health supplement market continues to increase. Demand in China for vitamins, infant formula and supplements sourced in Australia have surged increasingly over the past five years, with Chinese investment in Australia�s healthcare sector jumping from zero to $5.5billion in the past three years alone (KPMG)"
"In April 2017 the Company announced that it had entered into a memorandum of understanding with BY-HEALTH Co., Ltd which is intended to result in a research and collaboration agreement with BY-HEALTH for Fruitflow. The Company also confirmed separately that Provexis and DSM are working with BY-HEALTH to support the planned launch of some Fruitflow based products in the Chinese market."
" BY-HEALTH is a substantial Chinese listed dietary supplement business which is currently valued in excess of £2bn.
Could just as easily be up theft .
Please use the sharing tools found via the email icon at the top of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email email@example.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
�The US government�s recent assertions on China and IP theft are more to do with China�s status as an emerging �innovation nation�, which directly challenges the USA�s position as a leader in the area,� said Ms White.
That has created fears of pressure on foreign companies to transfer technology to Chinese companies � especially through licensing agreements and joint ventures.
One method China uses to achieve its strategic goals, according to a study on IP theft by China commissioned by the White House last August and released in March, is through restrictions on foreign investment. It uses this to selectively grant market access to foreign investors in exchange for commitments to transfer technology, the study said.
Over the past two decades, foreign makers of everything from high-speed trains to fighter planes have licensed the technology to Chinese partners only to find a few years later that their partner is a major international competitor.
But China has said its efforts at innovation-led growth are completely legal under World Trade Organization rules.
Mr Trump put the theft of intellectual property by China as probably in the neighbourhood of $200bn to $300bn. In spite of being � a very, very powerful country,� the US, said Mr Trump, had to �do something on trade with certain countries. And, obviously, China is the leader in terms of deficits�.
Yes, but any offer would be to PI's essentially, so would have to go to an EGM and be voted on. As you say, it would have to be substantial to interest DSM. It's a moot point, but trading activity doesn't support the theory. Wishful thinking perhaps, nothing wrong with that, musing about the multiples a holder with a low average could make is a pleasant pastime.
Seems to me to be unlikely . Let�s say for argument sake by health made an offer of �40 m ,DSM own 9%of Pxs, DSM would receive �3.6 m do you think they would be happy with that !or even 10 x that figure ,I think not. On the other hand the lack of news and predictable decline in the sp could be contrived to allow a cheap by- out.imho
The discussion on red is noted.
Have to say Wheelds, I don't agree.
To follow that strategy, and go from no notified holding to gaining control, they would surely need to be accumulating available shares. They're not, nobody is.
That's not to say it isn't a possibility in future, who knows? The influence of Chinese business strength is being felt in all areas of the world.